The administration of US President Donald Trump on Thursday published what it called a complete review of gender interventions for children and adolescents, infuriating parents about the” major risks” of puberty blockers and surgeries.
The Department of Health and Human Services justified the publication of the 400-page review in order to “help maintain the integrity of this process,” which is against accepted scientific standards.
In some nations, the issue of gender equality is a controversial issue, with health professionals trying to balance competing priorities for ensuring that any interventions are healthy, evidence-based, and ideal for developing bodies and minds.
Questions have been raised about the study’s honesty due to the Trump administration’s well-documented animosity toward transgender individuals and its repeated attacks on what it calls “woke female ideology.”
Infertility/sterility, sexual function, impaired bone density accrual, severe mental effects, cardiovascular disease and physiological disorders, psychiatric disorders, medical complications, and regret are all risks that gender-affirming treatments “pose,” according to the report.
The National Institutes of Health director, Jay Bhattacharya, said,” Our responsibility is to safeguard our nation’s children– not to expose them to untested and inevitable health interventions.” We must adhere to science’s “gold regular,” no activist agendas.
However, Aisha Mays, a California home doctors and board member of the organization Physicians for Reproductive Health, refrained from calling the report “propaganda.”
The report from today’s press is propaganda that seeks to vilify transgender people’s access to completely safe, effective, and evidence-based health care, she claimed.
” Being transgender is not a choice, nor can it be reversed by any health or social process, just like being cisgender,” according to the statement. In the same way that transgender people are aware of who they are, but are transgender people. In the same way that transgender individuals receive gender-affirming care, but do trans people.”
In the UK, a individual, well-known review recommended “extreme precaution” when prescribing hormone therapies.
Diffusions of recommendations were made during the four-year investigation into infant and youth gender identity services, which was led by retired physician Hilary Cass. These recommendations included changes to the referrals system, as well as more studies.
The American Academy of Pediatrics has continued to support the provision of medically important treatment for transgender children and opposes regulations that restricts for access or interacts with the doctor-patient marriage.
Although the political rants about gender equality have gotten louder, data shows that in actuality, such behavior is not common.
In a recent study published in JAMA Pediatrics, less than 0.1 % of gender-diverse juveniles who had personal healthcare received hormone therapy or puberty blockers between 2018 and 2022.
